TREACE MEDICAL CONCEPTS, INC. (TMCI): Price and Financial Metrics


TREACE MEDICAL CONCEPTS, INC. (TMCI): $14.49

-0.47 (-3.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TMCI Stock Price Chart Interactive Chart >

Price chart for TMCI

TMCI Price/Volume Stats

Current price $14.49 52-week high $32.30
Prev. close $14.96 52-week low $12.48
Day low $14.43 Volume 66,800
Day high $15.17 Avg. volume 223,361
50-day MA $16.39 Dividend yield N/A
200-day MA $19.69 Market Cap 800.99M

TREACE MEDICAL CONCEPTS, INC. (TMCI) Company Bio


Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.


TMCI Latest News Stream


Event/Time News Detail
Loading, please wait...

TMCI Latest Social Stream


Loading social stream, please wait...

View Full TMCI Social Stream

Latest TMCI News From Around the Web

Below are the latest news stories about Treace Medical Concepts Inc that investors may wish to consider to help them evaluate TMCI as an investment opportunity.

Treace Highlights New Product Innovations at the 2022 ACFAS Scientific Conference

PONTE VEDRA, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, announces it will highlight new product innovations at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference in Austin, Texas from February 24-27.

Yahoo | February 23, 2022

Treace to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

PONTE VEDRA, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Thursday, March 3, 2022. Company management will host a conference call to discuss financial results beginn

Yahoo | February 14, 2022

Fwl Investment Management, Llc Buys E2open Parent Holdings Inc, Cheniere Energy Inc, SPDR ...

Investment company Fwl Investment Management, Llc (Current Portfolio) buys E2open Parent Holdings Inc, Cheniere Energy Inc, SPDR Pharmaceuticals ETF, SPDR S&P Bank ETF, Twilio Inc, sells Snap Inc, Activision Blizzard Inc, Sunrun Inc, Magnite Inc, Simon Property Group Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Fwl Investment Management, Llc.

Yahoo | February 8, 2022

Treace to Announce Latest ALIGN3D™ Data at the 2022 ACFAS Scientific Conference

PONTE VEDRA, Fla., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, today announced the upcoming podium presentation of the latest interim analysis from the ALIGN3D™ clinical study at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Annual

Yahoo | February 1, 2022

Roubaix Capital, LLC Buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Sells Rogers ...

Investment company Roubaix Capital, LLC (Current Portfolio) buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Xometry Inc, First Citizens BancShares Inc, sells Rogers Corp, Alliance Data Systems Corp, Hayward Holdings Inc, Gates Industrial Corp PLC, Aspen Aerogels Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Roubaix Capital, LLC.

Yahoo | January 28, 2022

Read More 'TMCI' Stories Here

TMCI Price Returns

1-mo N/A
3-mo -23.37%
6-mo -22.26%
1-year -52.46%
3-year N/A
5-year N/A
YTD -22.26%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4213 seconds.